Guardant Health Q3 Adjusted EPS USD -0.29 Vs. IBES Estimate USD -0.32

By Reuters News

Nov 05 (Reuters) - Guardant Health Q3 revenue USD 361 million vs. IBES estimate USD 350.4 million.

  • Q3 EPS USD -0.93
  • Q3 adjusted EBITDA USD -37.3 million vs. IBES estimate USD -36.5 million
  • Q3 adjusted net income USD -38.8 million vs. IBES estimate USD -42.7 million
  • outlook FY revenue USD 1,360-1,370 million vs. IBES estimate USD 1,357 million

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk